A case of placental site trophoblastic tumor and a retrospective analysis

Placental site trophoblastic tumor (PSTT) refers to intermediates derived from intermediate trophoblasts, a particular type of tro-phoblastic tumor from the placenta site (gestational trophoblastic disease, GTD), whose pathological morphology and biological be-haviors and other trophoblastic tumors are very different. Here, the authors report one case of PSTT, which is from the Anhui Provincial Hospital Affiliated to Anhui Medical University. A 39-year-old woman presented with abnormal uterine bleeding for four months after she had an abortion. She underwent curettage surgery in a local hospital, revealing a pathology of choriocarcinoma. Methotrexate (MTX) chemotherapy was ineffective, and blood hCG continued to rise,while in this hospital ultrasonographic examination the bottom of the uterus exhibited a uneven echo, with ill-defined and unclear intrauterine boundaries and a “honeycomb” structure in the serosa. After hysterectomy ,pathology revealed a bottom PSTT with invasion of the muscle which was greater than 50%. Microscopically, the tumor consists of sheets of intermediate trophoblastic cells invading the myometrium. Immunohistochemistry showed positive results for PCK, inhibin, hPL, and β-HCG (spotty +). A course of combined EMA-CO chemotherapy was performed ten days after the surgery, and the patient was then discharged after reviewing the normal indicators.The patient was followed for 36 months without recurrence.

Placental site trophoblastic tumor; Hysterectomy; Pathology; Immunohistochemistry; Chemotherapy.

[1] Kurman R.J., Scully R.E., Norris H.J.: “Trophoblastic pseudotumor of the uterus. An exaggerated form of “syncytial endometritis” sim-ulating a malignant tumor”. Cancer, 1976, 38, 1214.

[2] Scully R.E., Young R.H.: “Trophoblastic pseudotumor: a reap-praisal”. Am. J. Pathol., 1981, 5, 75.

[3] Schmid P., Nagai Y., Agarwal R., Hancock B., Savage P.M., Sebire

N. J., et al.: “Prognostic markers and long-term outcome of placen-tal-site trophoblastic tumours: a retrospective observational study”. Lancet, 2009, 374, 48.

[4] Luiza J.W., Taylor S.E., Gao F.F., Edwards R.P.: “Placental site tro-phoblastic tumor: Immunohistochemistry algorithm key to diagnosis and review of literature”. Gynecol. Oncol. Case. Rep., 2014, 7, 13.

[5] Pongsaranantakul S., Kietpeerakool C.: “Hysterectomy in gestational trophoblastic neoplasia: Chiang Mai University Hospital’s experi-ence”. Asian Pac. J. Cancer. Prev., 2009, 10, 311.

[6] Zhao J., Lv W.G., Feng F.Z., Wan X.R., Liu J.H., Yi X.F., et al.: “Pla-cental site trophoblastic tumor: A review of 108 cases and their im-plications for prognosis and treatment”. Gynecol. Oncol., 2016, 142, 102.

[7] Hassadia A., Gillespie A., Tidy J., Everard R.G.N.J, Wells M., Coleman R., Hancock B.: “Placental site trophoblastic tumour: Clinical features and management”. Gynecol. Oncol., 2005, 99, 603.

Hyman D.M., Bakios L., Gualtiere G., Carr C., Grisham R.N., Makker V., et al.: “Placental site trophoblastic tumor: Analysis of presentation, treatment, and outcome”. Gynecol. Oncol., 2013, 129, 58.

[9] van Trommel N.E., Lok C.A., Bulten H., Thomas C.M., Massuger LF.: “Long-term outcome of placental site trophoblastic tumor in The Netherlands”. J. Reprod. Med., 2013, 58, 224.

[10] Xiao C., Zhao J., Li M., Zhao D., Xiang Y.: “Lupus nephritis asso-ciated with placental site trophoblastic tumor: A case report and re-view of the literature”. Gynecol. Oncol. Case. Rep.,2014, 9, 26.

[11] Harvey R.A., Pursglove H.D., Schmid P., Savage P.M., Mitchell D.C., Seckl M.J.: “Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors”. J. Reprod. Med., 2008, 53, 643.

[12] Cole L.A., Khanlian S.A., Muller C.Y.: “Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results”.

J. Reprod. Med., 2008, 53, 457.

[13] Okumura M., Fushida K., Rezende W.W., Schultz R., Zugaib M.: “Sonographic appearance of gestational trophoblastic disease evolving into epithelioid trophoblastic tumor”. Ultrasound. Obstet. Gy-necol., 2010, 36, 249.

[14] Saso S., Haddad J., Ellis P., Lindsay I., Sebire N.J., McIndoe A., et al.: “Placental site trophoblastic tumours and the concept of fertility preservation”. BJOG, 2012, 119, 369.

[15] Shen X., Xiang Y., Guo L., Feng F., Wan X., Xiao Y., et al.: “Fertil-ity-Preserving Treatment in Young Patients With Placental Site Tro-phoblastic Tumors”. Int. J. Gynecol. Cancer, 2012, 22, 869.

[16] Seckl M.J., Sebire N.J., Berkowitz R.S.: “Gestational trophoblastic disease”. BMJ, 2010, 376, 717.